ASPE logo

Aspen Neuroscience Inc.

ASPE
Healthcare|Biotechnology|US
$12.44
+0.68 (+5.78%)
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Oct 30, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Aspen Neuroscience Announces Pricing of Initial Public Offering
Oct 29, 2026 · GlobeNewsWire

SEC Filings (16)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Nov 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Nov 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Nov 3, 2026SC 13GPassive 5%+ stakeDocumentIndex
Nov 2, 2026S-8Employee stock planDocumentIndex
Nov 2, 20268-KMaterial eventDocumentIndex
Oct 30, 2026424B4Offering prospectusDocumentIndex
Oct 29, 2026EFFECTDocumentIndex
Oct 29, 2026CERTDocumentIndex
Oct 29, 20268-A12BDocumentIndex
Oct 26, 2026S-1/AIPO / offering registrationDocumentIndex
Oct 22, 2026S-1/AIPO / offering registrationDocumentIndex
Oct 9, 2026S-1IPO / offering registrationDocumentIndex
Jun 10, 2026DRS/ADocumentIndex
May 12, 2026DRS/ADocumentIndex
Mar 30, 2026DRSDocumentIndex